HUMBOLDT GENERAL HOSPITAL — History
CCN 291308 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$59M
Latest Revenue (FY2022)
+1.9%
Revenue CAGR (3yr)
-37.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $57M | $52M | $59M | +12.2% | +1.9% |
| Operating Expenses | $77M | $77M | $81M | +5.3% | +2.6% |
| Operating Margin | -35.5% | -46.3% | -37.3% | +19.5% | +0.0% |
| Net Income | $-20M | $-24M | $-22M | +9.7% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,993 | 4,372 | 4,153 | -5.0% | +2.0% |
| Medicare Day % | 61% | 50% | 59% | +17.1% | -1.5% |
| Medicaid Day % | 15% | 11% | 11% | -1.9% | -15.9% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +3.8% ($57M → $59M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.9%
This Hospital
+7.6%
State Avg
Latest Margin
-37.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $60M | -38.2% |
| FY2024 (proj) | $61M | -39.1% |
| FY2025 (proj) | $62M | -40.0% |